These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 31419737)

  • 1. Attitude and perceptions of patients towards long acting depot injections (LAIs).
    Grover S; Sahoo S; Bn S; Malhotra N; Dua D; Avasthi A
    Asian J Psychiatr; 2019 Aug; 44():200-208. PubMed ID: 31419737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-acting injectable antipsychotics (LAIs) for maintenance treatment of bipolar and schizoaffective disorders: A systematic review.
    Pacchiarotti I; Tiihonen J; Kotzalidis GD; Verdolini N; Murru A; Goikolea JM; Valentí M; Aedo A; Vieta E
    Eur Neuropsychopharmacol; 2019 Apr; 29(4):457-470. PubMed ID: 30770235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of second-generation antipsychotic long-acting injections (SGA LAIs) in maintenance treatment of bipolar disorder: protocol for a systematic review and meta-analysis.
    Prajapati AR; Wilson J; Maidment I
    BMJ Open; 2016 Jan; 6(1):e010237. PubMed ID: 26739743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A qualitative study of experiences with and perceptions regarding long-acting injectable antipsychotics: Part I-patient perspectives.
    Iyer S; Banks N; Roy MA; Tibbo P; Williams R; Manchanda R; Chue P; Malla A
    Can J Psychiatry; 2013 May; 58(5 Suppl 1):14S-22S. PubMed ID: 23945063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychiatrists' use, knowledge and attitudes to first- and second-generation antipsychotic long-acting injections: comparisons over 5 years.
    Patel MX; Haddad PM; Chaudhry IB; McLoughlin S; Husain N; David AS
    J Psychopharmacol; 2010 Oct; 24(10):1473-82. PubMed ID: 19477883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attitudes of patients and mental health staff to antipsychotic long-acting injections: systematic review.
    Waddell L; Taylor M
    Br J Psychiatry Suppl; 2009 Nov; 52():S43-50. PubMed ID: 19880916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second-generation antipsychotic long-acting injections in bipolar disorder: Systematic review and meta-analysis.
    Prajapati AR; Wilson J; Song F; Maidment I
    Bipolar Disord; 2018 Dec; 20(8):687-696. PubMed ID: 30417552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotic long-acting injections: A community-based study from 2007 to 2014 of prescribing trends and characteristics associated with initiation.
    Verdoux H; Pambrun E; Tournier M; Bezin J; Pariente A
    Schizophr Res; 2016 Dec; 178(1-3):58-63. PubMed ID: 27624680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A qualitative study of experiences with and perceptions regarding long-acting injectable antipsychotics: part II-physician perspectives.
    Iyer S; Banks N; Roy MA; Tibbo P; Williams R; Manchanda R; Chue P; Malla A
    Can J Psychiatry; 2013 May; 58(5 Suppl 1):23S-9S. PubMed ID: 23945064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical guideline recommendations for antipsychotic long-acting injections.
    Kane JM; Garcia-Ribera C
    Br J Psychiatry Suppl; 2009 Nov; 52():S63-7. PubMed ID: 19880920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attitude and influencing factors of patients with schizophrenia toward long-acting injections: A community-based cross-sectional investigation in China.
    Sun Y; Tong J; Feng Y; Fang H; Jiang T; Zhao L; Wang Q; Yang Y
    Front Public Health; 2022; 10():951544. PubMed ID: 36299738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Use of Long-Acting Injectable Antipsychotics in Schizophrenia: Evaluating the Evidence.
    Correll CU; Citrome L; Haddad PM; Lauriello J; Olfson M; Calloway SM; Kane JM
    J Clin Psychiatry; 2016; 77(suppl 3):1-24. PubMed ID: 27732772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsychotic long-acting injections in clinical practice: medication management and patient choice.
    Gray R; Spilling R; Burgess D; Newey T
    Br J Psychiatry Suppl; 2009 Nov; 52():S51-6. PubMed ID: 19880918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [French Society for Biological Psychiatry and Neuropsychopharmacology task force: Formal Consensus for the prescription of depot antipsychotics].
    Samalin L; Abbar M; Courtet P; Guillaume S; Lancrenon S; Llorca PM
    Encephale; 2013 Dec; 39 Suppl 4():189-203. PubMed ID: 24373464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do Long-Acting Injectable Antipsychotics Prevent or Delay Hospital Readmission?
    Maestri TJ; Mican LM; Rozea H; Barner JC
    Psychopharmacol Bull; 2018 Mar; 48(3):8-15. PubMed ID: 29713100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Acting Injectable Antipsychotics in Children and Adolescents.
    Lytle S; McVoy M; Sajatovic M
    J Child Adolesc Psychopharmacol; 2017 Feb; 27(1):2-9. PubMed ID: 28112539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists].
    Misdrahi D; Delgado A; Bouju S; Comet D; Chiariny JF
    Encephale; 2013 May; 39 Suppl 1():S8-14. PubMed ID: 23541914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perceptions of Psychiatrists Toward the Use of Long-Acting Injectable Antipsychotics: An Online Survey Study From India.
    Grover S; Sahoo S; Mehra A
    J Clin Psychopharmacol; 2019; 39(6):611-619. PubMed ID: 31688382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hospital Readmission Rates Among Patients With Schizophrenia Treated With Long-Acting Injectables or Oral Antipsychotics.
    MacEwan JP; Kamat SA; Duffy RA; Seabury S; Chou JW; Legacy SN; Hartry A; Eramo A; Karson C
    Psychiatr Serv; 2016 Nov; 67(11):1183-1188. PubMed ID: 27417897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of long-acting injectable antipsychotics vs. oral medication on relapses of patients with psychosis and bipolar disorder.
    Vgontzas AN; Paschalidou A; Simos PG; Anastasaki M; Zografaki A; Volikos E; Koutra K; Basta M
    Psychiatry Res; 2024 Feb; 332():115676. PubMed ID: 38176166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.